ArticleFrontiers in oncology2026

Multi-omics identification of MBNL2 associated with poor pathological response to neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma.

Hao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.